This is a report from the Agency for Healthcare Research and Quality (AHRQ) that provides guidance for first responders on determining optimal doses, routes of administration, and dosing strategies of naloxone for suspected opioid overdose in out-of-hospital settings, and whether transport to a…

This is an issue brief from the Network of Public Health Law that discusses mandatory stewardship programs as a way to increase appropriate drug disposal, thus decreasing non-medical opioid misuse in a community. In response to low rates of participation in voluntary drug take-back programs,…

This is a report from New America and the Public Interest Technology (authors Lindemann and Coleman) documenting the efforts of the Opioid Mapping Initiative, including the national naloxone access map and the national prescription drop-off map.

The information provided In this report…

This is a report that guides communities on effectively using potential opioid settlement money. There is specific focus on how communities can successfully invest one-time resources in sustainable, evidence-based early intervention, treatment, and recovery services.

This report describes the ways and extent to which state Medicaid programs covered peer support services for adult Medicare beneficiaries with substance use disorders (SUD) and how three state Medicaid programs - Colorado, Missouri, and Oregon - offered these services. The experience of these…

This is a report from Milbank and Academy Health that highlights innovative delivery models for Medicaid beneficiaries with opioid use disorder (OUD), including opioid health homes, warm handoffs, and care transitions. As the primary payer for OUD treatment, state Medicaid programs are uniquely…

This is a report from the National Association of Medicaid Directors that offers states options to consider to promote the health and wellbeing of Medicaid beneficiaries and expand access to behavioral health services. It includes strategies along a continuum of need, ranging from upstream…

This is a downloadable report from the Robert Wood Johnson Foundation that assists state policymakers in understanding the Medicaid program and their role in leveraging it to improve the health of their states’ residents and communities in the context of the opioid crisis. 

This is a report from Manatt Health and funded by the Robert Wood Johnson Foundation that reviews Medicaid strategies to combat the opioid crisis, with a focus on payment, delivery, and waiver strategies. 

This brief from the Office of Assistant Secretary for Planning and Evaluation (ASPE) describes four key challenges related to the use of medications for opioid use disorder (MOUD) in child welfare contexts for parents with opioid use disorder. It draws on results from a mixed-methods study…

This is a report from the Legal Action Center and the Center for Court Innovation that is designed to help drug court practitioners understand medications for opioid use disorder (MOUD) and to provide strategies for incorporating MOUD into their practice. Different MOUD models are discussed that…

This technical brief, a publication of the Agency for Healthcare Research and Quality (AHRQ), describes promising and innovative medications for opioid use disorder (MOUD) models of care in primary care settings, describes barriers to MOUD implementation, summarizes the evidence available on…

This is an academic paper that summarizes the evidence supporting medications for opioid use disorder (MOUD). It provides an overview of the pharmacology of MOUD, and discusses clinical indications for each form of MOUD.…

This is an academic paper that provides a synopsis of the evidence for buprenorphine in treating opioid use disorder (OUD). The study concludes that buprenorphine is associated with improved outcomes compared with placebo for individuals and pregnant women with OUD and that buprenorphine…

This is an academic paper that provides a synopsis of the evidence for methadone as a medication for opioid use disorder (MOUD). The study concludes that methadone is associated with improved outcomes for individuals and pregnant women with opioid use disorders, and that methadone should be a…

This is a report from SAMHSA for a wide range of stakeholders (healthcare professionals, policymakers, patients, and families) that gives an overview of the three FDA-approved medications used to treat opioid use disorder (OUD) as well as other strategies and services needed to support recovery…

This is a consensus study report of the National Academies of Sciences, Engineering, and Medicine put together by a committee of experts in the field. It summarizes the evidence on medications for opioid use disorder (MOUD), discusses the use of and evidence for these medications in different…

This report from SAMHSA provides an updated overview of three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and other strategies and services needed to support people in treatment. It is targeted towards healthcare…

This academic paper investigates the impact of implementing harm reduction programs in a hospital care setting. The results indicate that the implementation was successful and that the authors' program was able to better educate and engage patients, staff, and clinicians in harm reduction…

This is an academic paper that describes the collaboration between a multidisciplinary team of university, state and federal agency, and community experts to create a unified database linking controlled substance prescribing, overdose, and treatment for opioid use disorder in Connecticut that…